# Vitalant – FDA Inspection, Aug 7, 2024

Source: https://www.keypedia.com/records/fda_inspections/vitalant/f300122d-3b5f-4420-8224-64f4b3e47fc9
Source feed: FDA_Inspections

> FDA inspection 1247163 of Vitalant, August 07, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247163
- Company Name: Vitalant
- Inspection Date: 2024-08-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1076433 - 2018-11-27
- FDA Inspection 999732 - 2016-12-07
- FDA Inspection 911710 - 2015-01-14
- FDA Inspection 810328 - 2012-12-12
- FDA Inspection 720616 - 2011-04-19

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)
- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/vitalant/53210f12-3fe2-4006-a446-a8f926583960

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d